SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-06-000166
Filing Date
2006-02-10
Accepted
2006-02-10 17:04:45
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 memory_sc13g.htm SC 13G/A 102707
  Complete submission text file 0000898432-06-000166.txt   104757
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address
Business Address 100 PHILIPS PARKWAY MONTVALE NJ 07645 2018027100
MEMORY PHARMACEUTICALS CORP (Subject) CIK: 0001062216 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-80464 | Film No.: 06599537
SIC: 2834 Pharmaceutical Preparations